DE2215231A1 - Chinoxalin-di-N-oxide und deren Verwendung - Google Patents

Chinoxalin-di-N-oxide und deren Verwendung

Info

Publication number
DE2215231A1
DE2215231A1 DE19722215231 DE2215231A DE2215231A1 DE 2215231 A1 DE2215231 A1 DE 2215231A1 DE 19722215231 DE19722215231 DE 19722215231 DE 2215231 A DE2215231 A DE 2215231A DE 2215231 A1 DE2215231 A1 DE 2215231A1
Authority
DE
Germany
Prior art keywords
radical
quinoxaline
carbon atoms
methyl
formula
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
DE19722215231
Other languages
German (de)
English (en)
Inventor
Timothy Henry Niantic; Richardson Kenneth North Stonington; Conn. Cronin (V.StA.). M
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Pfizer Inc
Original Assignee
Pfizer Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US00135792A external-priority patent/US3818007A/en
Application filed by Pfizer Inc filed Critical Pfizer Inc
Publication of DE2215231A1 publication Critical patent/DE2215231A1/de
Pending legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D241/00—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings
    • C07D241/36—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings condensed with carbocyclic rings or ring systems
    • C07D241/50—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings condensed with carbocyclic rings or ring systems with hetero atoms directly attached to ring nitrogen atoms
    • C07D241/52—Oxygen atoms
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23K—FODDER
    • A23K20/00—Accessory food factors for animal feeding-stuffs
    • A23K20/10—Organic substances
    • A23K20/116—Heterocyclic compounds
    • A23K20/137—Heterocyclic compounds containing two hetero atoms, of which at least one is nitrogen
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23K—FODDER
    • A23K50/00—Feeding-stuffs specially adapted for particular animals
    • A23K50/30—Feeding-stuffs specially adapted for particular animals for swines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D263/00—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings
    • C07D263/02—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings
    • C07D263/08—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
    • C07D263/10—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
    • C07D263/14—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms with radicals substituted by oxygen atoms

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Polymers & Plastics (AREA)
  • Engineering & Computer Science (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Husbandry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Food Science & Technology (AREA)
  • Zoology (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Birds (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
DE19722215231 1971-04-20 1972-03-29 Chinoxalin-di-N-oxide und deren Verwendung Pending DE2215231A1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US00135792A US3818007A (en) 1970-03-18 1971-04-20 Hydroxyalkyl esters of quinoxaline-di-n-oxide-2-carboxylic acid

Publications (1)

Publication Number Publication Date
DE2215231A1 true DE2215231A1 (de) 1972-12-07

Family

ID=22469691

Family Applications (1)

Application Number Title Priority Date Filing Date
DE19722215231 Pending DE2215231A1 (de) 1971-04-20 1972-03-29 Chinoxalin-di-N-oxide und deren Verwendung

Country Status (17)

Country Link
JP (1) JPS5562074A (xx)
AR (2) AR199892A1 (xx)
AT (1) AT318617B (xx)
AU (1) AU467477B2 (xx)
BE (1) BE781363R (xx)
CA (1) CA982133A (xx)
DE (1) DE2215231A1 (xx)
DK (1) DK142849B (xx)
ES (1) ES401333A2 (xx)
FI (1) FI54473C (xx)
FR (1) FR2133597B2 (xx)
GB (1) GB1377306A (xx)
IT (1) IT1050210B (xx)
NL (1) NL7204391A (xx)
PH (1) PH9724A (xx)
SE (1) SE394279B (xx)
ZA (1) ZA722025B (xx)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2350096A1 (fr) 1976-05-03 1977-12-02 Oreal Compositions destinees a la coloration de la peau a base de derives de la quinoxaline
CN103288764B (zh) * 2013-04-25 2015-03-25 烟台绿叶动物保健品有限公司 喹羟酮丙氨酸酯盐酸盐及其制备方法

Also Published As

Publication number Publication date
AT318617B (de) 1974-11-11
CA982133A (en) 1976-01-20
ZA722025B (en) 1972-12-27
JPS56431B2 (xx) 1981-01-08
FI54473C (fi) 1978-12-11
AR203005A1 (es) 1975-08-08
AR199892A1 (es) 1974-10-08
FR2133597A2 (xx) 1972-12-01
BE781363R (fr) 1972-09-29
FI54473B (fi) 1978-08-31
FR2133597B2 (xx) 1975-12-26
AU467477B2 (en) 1973-09-20
IT1050210B (it) 1981-03-10
JPS5562074A (en) 1980-05-10
SE394279B (sv) 1977-06-20
PH9724A (en) 1976-02-27
NL7204391A (xx) 1972-10-24
ES401333A2 (es) 1975-03-16
DK142849B (da) 1981-02-09
GB1377306A (en) 1974-12-11
AU4002472A (en) 1973-09-20
DK142849C (xx) 1981-09-28

Similar Documents

Publication Publication Date Title
DE1620114C3 (de) Schiffsche Basen von 2 Formyl chinoxalin 1,4 dioxiden
EP0882049B1 (de) Gegebenenfalls substituierte 8-cyan-1-cyclopropyl-7-(2,8-diazabicyclo- 4.3.0]-nonan-8-yl)-6-fluor-1,4-dihydro-4-oxo-3-chinolincarbonsäuren und ihre derivate
DE1470439B1 (de) Chinolinderivate und Verfahren zu ihrer Herstellung
EP1071664A1 (de) Substituierte 2-oxo-alkansäure- 2-(indol-3-yl)-ethyl]amide
CH651299A5 (en) 1,4-Dioxoquinoxalin-2-yl ethenyl ketones and process for the preparation thereof, and their use in fattening animals
DE2354252A1 (de) Neue derivate des chinoxalin-n hoch 1, n hoch 4 -dioxids und diese enthaltende physiologisch und pharmakologisch wirksame mittel
DE2701707C2 (de) Chinoxalin-di-N-oxid-Derivate
DE2111710A1 (de) Substituierte Chinoxalin-1,4-dioxide und deren Verwendung
DE2215231A1 (de) Chinoxalin-di-N-oxide und deren Verwendung
DD285350A5 (de) Verfahren zur herstellung von substituierten pyridinethanolaminen
DE2801412A1 (de) 1,4-dioxo- und 4-oxo-chinoxalin-2- carboxaldehyd-sulfonylhydrazone und bestimmte derivate hiervon
DE2542899C3 (de) Substituierte Chinoxalin-2-carboxamid-l,4-dioxide
DE2105112A1 (de) Chinoxahn di Noxide und ihre Verwendung in einem pharmazeutischen Gemisch
DE2212932A1 (de) Verfahren zur Herstellung von Chinoxalin-di-N-oxiden
DE2120501C3 (de) Substituierte Chinoxalin-2-carboxamid-l,4-dioxide
DE2215320A1 (de) Verfahren zur Herstellung von Chinoxalin-di-N-oxyden
CH648025A5 (de) Chinoxalin-1,4-dioxyd-derivate.
DE2035797A1 (de) Neue Nitrofurandenvate , ein Verfahren zu ihrer Herstellung sowie ihre Verwendung als Arzneimittel
DE3312425A1 (de) Stoffmischungen mit wachstumsfoerdernder und leistungssteigernder wirkung sowie futtermittel und traenkfluessigkeiten, die geringe mengen dieser stoffmischungen enthalten
US3907994A (en) Substituted alkyl esters quinoxaline-di-N-oxide-2-carboxylic acid as growth promoting agents
US4007184A (en) Substituted alkyl esters of quinoxaline-di-N-oxide-2-carboxylic acid
DE19633805A1 (de) Gegenenenfalls substituierte 8-Cyan-l-cyclopropyl-7-(2,8-diazabicyclo-[4.3.0]-nonan-8-yl)-6-fluor-1,4-dihydro-4-oxo-3-chinolincarbonsäuren und ihre Derivate
EP0907648B1 (de) 7-(3-vinyl-1,4-piperazin-1-yl)-substituierte chinoloncarbonsäuren
EP0012725A1 (de) Chinoxalin-Di-N-oxid-Derivate, Verfahren zu ihrer Herstellung, Mittel diese enthaltend und ihre Verwendung
EP0339345A2 (de) 4-Brom-6-chlor-5-amino-2-pyridyl-ethanolamine, Verfahren zu ihrer Herstellung und ihre Verwendung als Leistungsförderer

Legal Events

Date Code Title Description
OD Request for examination
OHW Rejection